loss interferon antibodi prolong continu interferon-alpha therapi hairi cell leukemia activ hairi cell leukemia hcl interferon ifn cur diseas current data ifn therapi necessari diseas major patient ifn resist associ ifn-alpha antibodi small number patient hcl find requisit long-term therapi incid time antibodi follow-up studi ifn antibodi patient continu ifn therapi patient antibodi neg surprisingli patient non-neutr ifn antibodi antibodi neg median month patient antibodi antibodi neg non-neutr antibodi median month time antibodi patient neutral antibodi inhibit neopterin synthesi inhibit gener oligoadenyl synthetas activ inabl ifn serum subcutan inject ifn-alpha patient ifn antibodi antibodi function signific vivo ifn antibodi effect ifn vivo antibodi long-term therapi long-term effect drug like patient antibodi 